STEAP1 and neoplasm: Overall, these analyses indicate that CBD-IL-12 treatment reverts the hostile immunosuppressive tumor milieu to a proinflammatory state and broadens antitumor activity in conjunction with adoptively transferred STEAP1-mBBζ CAR T cell therapy.